Tag: ESMINT 2023
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Cerevasc announces presentation of initial eShunt data at ESMINT 2023
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...
Women in Neurointervention: How do we boost representation within “male-dominated” field?
Female representation in the neurointerventional world may be growing, but Johanna Fifi (Mount Sinai, New York, USA) and Anne-Christine Januel (Toulouse University Hospital, Toulouse,...
